Advances in the pharmacogenetic prediction of antipsychotic response

Toxicology

Volumn 192, Issue 1, 2003, Pages 33-35

  Arranz, M J ^a   Kerwin, R W ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antipsychotic response; Pharmacogenetic prediction; Pharmacogenetics

Indexed keywords

CLOZAPINE; DOPAMINE 3 RECEPTOR; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SEROTONIN; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ALLELE; ALZHEIMER DISEASE; BINDING AFFINITY; DOPAMINERGIC SYSTEM; DRUG BINDING; DRUG TARGETING; ETHNOLOGY; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LONG TERM CARE; PHARMACOGENETICS; PREDICTION; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHOSIS; RECEPTOR GENE; SAMPLING; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; SHORT SURVEY; STATISTICAL SIGNIFICANCE; TARDIVE DYSKINESIA; TREATMENT OUTCOME;

EID: 0141495008     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(03)00248-8     Document Type: Article

References (9)

1. Arranz M.J., Munro J., Sham P., Kirov G., Murray R.M., Collier D.A., et al. Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response. Schizophr. Res. 32:1998;93-99.
2. Arranz M.J., Munro J., Birkett J., Bolonna A.A., Mancama D., Sodhi M., et al. Pharmacogenetic prediction of clozapine response. Lancet. 355:2000;1615-1616.
3. Cacabelos R., Alvarez A., Fenandez-Novoa L., Lombardi V.R. A pharmacogenomic approach to Alzheimer's disease. Acta Neurol. Scand. 176:(Suppl.):2000;12-19.
4. Kim D.K., Lim S.-W., Lee S., Sohn S.E., Kim S., Hahn C.G., et al. Serotonin transporter gene polymorphism and antidepressant response. Neuroreport. 11:(1):2000;215-219.
5. Lerer B., Segman R.H., Fangerau H., Daly A.K., Basile V.S., Cavallaro R., et al. Pharmacogenetics of tardive dyskinesia. Combined analysis of 780 patients supports association with dopamine d3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology. 27:(1):2002;105-119.
6. Malhotra A.K., Buchanan R.W., Kim S., Kestler L., Breier A., Pickar #d, et al. Allelic variation in the promoter region of the dopamine D2 receptor gene and clozapine response. Schizophr. Res. 36:(1-3):1999;92-93.
7. Schafer M., Rujescu D., Giegling I., Guntermann A., Erfurth A., Bondy B., et al. Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene. Am. J. Psychiatry. 158:(5):2001;802-804.
8. Smeraldi E., Zanardi R., Benedetti F., Di Bella D., Perez J., Catalano M. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol. Psychiatry. 3:1998;508-511.
9. Staddon S., Arranz M., Mancama D., Mata I., Kerwin R. Clinical application of pharmacogenetics in psychiatry. Psychopharmacology. 162:2002;18-23.